drugset / Trial / NCT00738400
Study of Vardenafil in Patients Suffering From Erectile Dysfunction and Metabolic Syndrome
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a controlled, randomized, multi-center prospective study of vardenafil to determine efficacy on Erectile Dysfunction (ED), tolerability and safety in men with ED and Metabolic Syndrome. This study will explore the rate of patients who do need to switch to the highest dosage based upon the expectation that most men can stay on vardenafil 10 mg PRN (pro re nata)
Timeline
- Start
- 2008-11
- Primary completion
- 2009-10
- Completion
- 2009-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vardenafil | Small molecule | 5 mg | — |
| Subject | Vardenafil | Small molecule | 10 mg | — |
| Subject | Vardenafil | Small molecule | 20 mg | — |